FDA acceptance for Amphetamine XR-Oral Suspension
Post# of 11
(Total Views: 403)
Posted On: 01/18/2017 1:46:21 PM
FDA acceptance for Amphetamine XR-Oral Suspension expected this or early next Week should push the stock closer or maybe over $7 .GL
•Amphetamine XR-Oral Suspension —NDA Submitted Nov 15, 2016
•Cotempla (methylphenidate) XR-ODT —NDA resubmitted Dec 20, 2016
•Amphetamine XR-Oral Suspension —NDA Submitted Nov 15, 2016
•Cotempla (methylphenidate) XR-ODT —NDA resubmitted Dec 20, 2016
(0)
(0)Neos Therapeutics, Inc. (NEOS) Stock Research Links
Scroll down for more posts ▼